Health technology assessment and its influence on health-care priority setting.
In this article, we review the development of health technology assessment (HTA) in England and Wales, France, The Netherlands, and Sweden, and we summarize the reaction to these developments from a variety of different disciplinary and stakeholder perspectives (political science, sociology, economics, ethics, public health, general practice, clinical medicine, patients, and the pharmaceutical industry). We conclude that translating HTA into policy is a highly complex business and that, despite the growth of HTA over the past two decades, its influence on policy making, and its perceived relevance for people from a broad range of different perspectives, remains marginal.
Oliver
Adam
A
London School of Economics and Political Science.
Mossialos
Elias
E
Robinson
Ray
R
D005060:Europe; D015276:Health Care Rationing; D006292:Health Priorities; D006801:Humans; D011050:Policy Making; D011634:Public Health; D013548:Sweden; D013673:Technology Assessment, Biomedical; D006113:United Kingdom